Mansat-De Mas V - Search Results

1

Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.

Delavigne K, Bérard E, Bertoli S, Corre J, Duchayne E, Demur C, Mansat-De Mas V, Borel C, Picard M, Alvarez M, Sarry A, Huguet F, Récher C. Delavigne K, et al. Haematologica. 2014 Mar;99(3):474-80. doi: 10.3324/haematol.2013.097394. Epub 2013 Oct 18. Haematologica. 2014. PMID: 24142998 Free PMC article.

2

Protein kinase C-zeta overexpression induces erythroid phenotype in the monocytic leukaemia cell line U937.

Mansat-De Mas V, de Thonel A, Gaulin V, Demur C, Laurent G, Quillet-Mary A. Mansat-De Mas V, et al. Br J Haematol. 2002 Aug;118(2):646-53. doi: 10.1046/j.1365-2141.2002.03625.x. Br J Haematol. 2002. PMID: 12139760 Free article.

3

Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis.

Recher C, Ysebaert L, Beyne-Rauzy O, Mansat-De Mas V, Ruidavets JB, Cariven P, Demur C, Payrastre B, Laurent G, Racaud-Sultan C. Recher C, et al. Cancer Res. 2004 May 1;64(9):3191-7. doi: 10.1158/0008-5472.can-03-3005. Cancer Res. 2004. PMID: 15126359

4

Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells.

Beyne-Rauzy O, Recher C, Dastugue N, Demur C, Pottier G, Laurent G, Sabatier L, Mansat-De Mas V. Beyne-Rauzy O, et al. Oncogene. 2004 Sep 30;23(45):7507-16. doi: 10.1038/sj.onc.1208024. Oncogene. 2004. PMID: 15326480

5

Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells.

Beyne-Rauzy O, Prade-Houdellier N, Demur C, Recher C, Ayel J, Laurent G, Mansat-De Mas V. Beyne-Rauzy O, et al. Blood. 2005 Nov 1;106(9):3200-5. doi: 10.1182/blood-2005-04-1386. Epub 2005 Jul 14. Blood. 2005. PMID: 16020509 Free article.

6

TNFalpha stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells.

Guilloton F, de Thonel A, Jean C, Demur C, Mansat-De Mas V, Laurent G, Quillet-Mary A. Guilloton F, et al. Leukemia. 2005 Dec;19(12):2206-14. doi: 10.1038/sj.leu.2403952. Leukemia. 2005. PMID: 16239914

7

Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.

Ysebaert L, Chicanne G, Demur C, De Toni F, Prade-Houdellier N, Ruidavets JB, Mansat-De Mas V, Rigal-Huguet F, Laurent G, Payrastre B, Manenti S, Racaud-Sultan C. Ysebaert L, et al. Leukemia. 2006 Jul;20(7):1211-6. doi: 10.1038/sj.leu.2404239. Epub 2006 May 11. Leukemia. 2006. PMID: 16688229

8

Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.

Paupert J, Mansat-De Mas V, Demur C, Salles B, Muller C. Paupert J, et al. Cell Cycle. 2008 Apr 15;7(8):1047-53. doi: 10.4161/cc.7.8.5645. Epub 2008 Jan 18. Cell Cycle. 2008. PMID: 18414048

9

Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapy.

Cavelier C, Didier C, Prade N, Mansat-De Mas V, Manenti S, Recher C, Demur C, Ducommun B. Cavelier C, et al. Cancer Res. 2009 Nov 15;69(22):8652-61. doi: 10.1158/0008-5472.CAN-09-0939. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843865

10

The cell cycle regulator CDC25A is a target for JAK2V617F oncogene.

Gautier EF, Picard M, Laurent C, Marty C, Villeval JL, Demur C, Delhommeau F, Hexner E, Giraudier S, Bonnevialle N, Ducommun B, Récher C, Laurent G, Manenti S, Mansat-De Mas V. Gautier EF, et al. Blood. 2012 Feb 2;119(5):1190-9. doi: 10.1182/blood-2011-01-327742. Epub 2011 Nov 7. Blood. 2012. PMID: 22065597 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters